Amobarbital

异戊巴比妥

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmobarbital
Drug Alias NameAmobarbitalum阿米妥Amylobarbitone異戊巴比妥Amytal
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationSleep Initiation and Maintenance DisordersSeizures
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSedationSleep Initiation and Maintenance DisordersSeizures
Inactive IndicationsN/A

Other Information

ATC CodeN05CA02